Table 1.
Selected baseline sample characteristics by CV-GID; elderly with osteoarthritis (n = 45,385), 2015–2016.
| Variable | CVD or GI AEs |
No CVD or GI AEs |
p-value | ||
|---|---|---|---|---|---|
| N | Percentage | N | Percentage | ||
| All | 26,769 | 59.0 | 18,616 | 41.0 | |
| Age | <0.001 | ||||
| 65–69 | 5334 | 51.4 | 5039 | 48.6 | |
| 70–74 | 6377 | 56.0 | 5004 | 44.0 | |
| 75–79 | 5455 | 60.4 | 3574 | 39.6 | |
| 80 and over | 9603 | 65.8 | 4999 | 34.2 | |
| Sex | <0.001 | ||||
| Female | 17,408 | 57.8 | 12,687 | 42.2 | |
| Male | 9361 | 61.2 | 5929 | 38.8 | |
| Insurance Type | <0.001 | ||||
| HMO | 9369 | 56.8 | 7128 | 43.2 | |
| Other | 17,400 | 60.2 | 11,488 | 39.8 | |
| Diabetes | <0.001 | ||||
| Yes | 11,017 | 63.4 | 6350 | 36.6 | |
| No | 15,752 | 56.2 | 12,266 | 43.8 | |
| Hyperlipidemia | <0.001 | ||||
| Yes | 19,778 | 63.4 | 11,441 | 36.6 | |
| No | 6991 | 49.4 | 7175 | 50.6 | |
| Hypertension | <0.001 | ||||
| Yes | 22,609 | 63.7 | 12,888 | 36.3 | |
| No | 4160 | 42.1 | 5728 | 57.9 | |
| Obesity | <0.001 | ||||
| Yes | 5346 | 64.4 | 2952 | 35.6 | |
| No | 21,423 | 57.8 | 15,664 | 42.2 | |
| H.pylori infection | 0.018 | ||||
| Yes | 275 | 85.1 | 48 | 14.9 | |
| No | 26,494 | 58.8 | 18,568 | 41.2 | |
| Polypharmacya | <0.001 | ||||
| Yes | 17,759 | 67.3 | 8635 | 32.7 | |
| No | 9010 | 47.4 | 9981 | 52.6 | |
| OA-related pain | <0.001 | ||||
| Yes | 16,879 | 61.6 | 10,518 | 38.4 | |
| No | 9890 | 55.0 | 8098 | 45.0 | |
| Cardiac arrhythmia | <0.001 | ||||
| (continued) | |||||
| Yes | 8666 | 76.9 | 2598 | 23.1 | |
| No | 18,103 | 53.1 | 16,018 | 46.9 | |
|
Continuous Variables | |||||
|
Mean |
SD |
Mean |
SD |
p-value |
|
| Fragmentation of Care Index (FCI) | 0.70 | 0.20 | 0.60 | 0.20 | <0.001 |
| Duration of non-selective NSAID use (days) | 28.2 | 78.2 | 30.4 | 80.7 | 0.003 |
| Duration of selective NSAID use (days) | 6.2 | 40.1 | 5.1 | 36.1 | 0.002 |
| Number of IA corticosteroid injections | 0.9 | 1.6 | 0.7 | 1.3 | 0.009 |
| Duration of prescription opioids (days) | 47.7 | 97.8 | 30.5 | 79.6 | <0.001 |
| Duration of GPA use (days) | 109.5 | 164.1 | 26.1 | 90.1 | <0.001 |
| Number of physical therapy visits | 4.8 | 12.9 | 3.6 | 10.3 | <0.001 |
| Number of orthopedic doctor visits | 1.7 | 3.2 | 1.4 | 2.8 | <0.001 |
| Number of rheumatologist visits | 0.3 | 1.1 | 0.2 | 1.1 | 0.001 |
| Duration of oral corticosteroids (days) | 55.7 | 103.8 | 48.5 | 97.5 | 0.002 |
Note: The sample includes 45,385 elderly with osteoarthritis from De-identified Optum Clinformatics Data Mart (2014–2015).
∗Excludes opioid and NSAID combinations.
CVD-cardiovascular disease; GI- gastrointestinal; GPA-gastroprotective agents; HMO, health maintenance organization; IA-intra-articular; NSAID-non-steroidal anti-inflammatory drugs; OA-osteoarthritis; SD - standard deviation.
Polypharmacy was defined as the use of 6 or more different classes of medications.